|
Lower bounds for the number of items with the maximum score for several studies. N is the number of items that constitute the (sub)scale, Sm is the maximum possible individual item score, n is the reported number of subjects, |
||||||
| Scale |
N |
Sm |
n |
![]() |
L |
![]() |
|
|
||||||
| Checklist Individual Strength |
Oxford-CFS, CDC94-UCF; Vercoulen et al. [10] |
|||||
|
|
||||||
| -fatigue severity subscale |
8 |
7 |
758 |
51.7 |
2805 |
46% |
| -physical activity subscale |
3 |
7 |
758 |
16.9 |
0 |
0% |
| -reduced motivation subscale |
4 |
7 |
758 |
17.0 |
0 |
0% |
| -concentration subscale |
5 |
7 |
758 |
27.5 |
0 |
0% |
|
|
||||||
| Checklist Individual Strength |
CDC94-UCF; van der Werf et al. [21] |
|||||
|
|
||||||
| -homebound group; fatigue severity subscale |
8 |
7 |
18 |
53.6 |
101 |
70% |
| -matched ambulant group; fatigue severity subscale |
8 |
7 |
32 |
52.8 |
154 |
60% |
| -total ambulant group; fatigue severity subscale |
8 |
7 |
270 |
52.1 |
1107 |
51% |
| -homebound group; physical activity subscale |
3 |
7 |
18 |
15.8 |
0 |
0% |
| -matched ambulant group; physical activity subscale |
3 |
7 |
32 |
17.0 |
0 |
0% |
| -total ambulant group; physical activity subscale |
3 |
7 |
270 |
17.6 |
0 |
0% |
| -homebound group; concentration subscale |
5 |
7 |
15 |
22.4 |
0 |
0% |
|
|
||||||
| Shortened Fatigue Questionnaire |
van der Werf et al. [22] |
|||||
|
|
||||||
| -survey respondents (Dutch ME-Association members) |
4 |
7 |
1955 |
23.9 |
0 |
0% |
| -research participants (CDC94-UCF) |
4 |
7 |
270 |
26.1 |
567 |
53% |
|
|
||||||
| Shortened Fatigue Questionnaire |
Oxford-CFS, CDC94-UCF; Alberts et al. [11] |
|||||
|
|
||||||
| -normative data for CFS |
4 |
7 |
445 |
26 to 27 |
890 |
50% |
|
|
||||||
| Shortened Fatigue Questionnaire |
CDC94-CFS; Vermeulen et al. [12] |
|||||
| -study group |
4 |
7 |
35 |
24.8 |
28 |
20% |
|
|
||||||
| Krupp Fatigue Severity Scale |
CDC88-CFS; Friedberg et al. [19] |
|||||
|
|
||||||
| -treatment group |
9 |
7 |
22 |
58 |
88 |
44% |
| -no-treatment group |
9 |
7 |
22 |
51 |
0 |
0% |
|
|
||||||
| Krupp Fatigue Severity Scale |
CDC88-CFS; DeLuca et al. [23] |
|||||
|
|
||||||
| -subjects with concurrent axis 1 psychiatric disorder |
9 |
7 |
12 |
58.5 |
54 |
50% |
| -subjects without concurrent psychiatric disorder |
9 |
7 |
21 |
57.2 |
67 |
36% |
|
|
||||||
| 14-item Chalder Fatigue Scale |
Oxford-CFS; Wearden et al. [15] |
|||||
|
|
||||||
| -'exercise and fluoxetine group' |
14 |
3 |
33 |
35.9 |
261 |
56% |
| -'exercise and placebo group' |
14 |
3 |
34 |
33.7 |
194 |
41% |
| -'exercise control and fluoxetine group' |
14 |
3 |
35 |
34.4 |
224 |
46% |
| -'exercise control and placebo group' |
14 |
3 |
34 |
34.0 |
204 |
43% |
|
|
||||||
| 14-item Chalder Fatigue Scale |
Oxford-CFS; Fulcher et al. [16] |
|||||
|
|
||||||
| -exercise group |
14 |
3 |
33 |
28.9 |
30 |
6% |
| -fiexibility group |
14 |
3 |
33 |
30.5 |
83 |
18% |
|
|
||||||
| 11-item Chalder Fatigue Scale |
CDC94-CFS; Jason et al. [13] |
|||||
|
|
||||||
| -physical subscale |
7 |
3 |
15 |
18.40 |
66 |
63% |
| -mental subscale |
4 |
3 |
15 |
9.13 |
17 |
28% |
|
|
||||||
| 11-item Chalder Fatigue Scale |
CDC94-CFS; Wallman et al. [17] |
|||||
|
|
||||||
| -exercise group; physical subscale |
7 |
3 |
32 |
11.6 |
0 |
0% |
| -exercise group; mental subscale |
4 |
3 |
32 |
6.3 |
0 |
0% |
| -relaxation/flexibility group; physical subscale |
7 |
3 |
29 |
11.4 |
0 |
0% |
| -relaxation/flexibility group; mental subscale |
4 |
3 |
29 |
5.6 |
0 |
0% |
|
|
||||||
| 11-item bimodal Chalder Fatigue Scale |
Oxford-CFS and CDC94-CFS; Deale et al. [20] |
|||||
|
|
||||||
| -cognitive behavior therapy group |
11 |
1 |
30 |
10.1 |
303 |
92% |
| -relaxation group |
11 |
1 |
30 |
9.3 |
279 |
85% |
|
|
||||||
| 11-item bimodal Chalder Fatigue Scale |
Oxford-CFS; Powell et al. [18] |
|||||
|
|
||||||
| -control group |
11 |
1 |
34 |
10.6 |
360 |
96% |
| -minimum intervention group |
11 |
1 |
37 |
10.4 |
385 |
95% |
| -telephone intervention group |
11 |
1 |
39 |
9.9 |
386 |
90% |
| -maximum intervention group |
11 |
1 |
38 |
10.2 |
388 |
93% |
Stouten BMC Health Services Research 2005 5:37 doi:10.1186/1472-6963-5-37 |
||||||